Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a share buyback of 108,000 shares for a total expenditure of HKD 1.486 million on October 13, 2025 [1] Group 1 - The company executed a buyback program, indicating confidence in its stock value [1] - The total amount spent on the buyback was HKD 1.486 million [1] - The number of shares repurchased was 108,000 [1]

康宁杰瑞制药-B(09966)发布公告，于2025年10月13日斥资148.6万港元回购10.8万股。 ...

翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) FF305 表格類別： 股票 狀態： 新提交 公司名稱： 康寧傑瑞生物製藥 呈交日期： 2025年10月13日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 09966 | 說明 | 普通股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | | ...

Group 1: Hong Kong Stocks - MicroPort Scientific Corporation-B (02252) rose over 3% as it announced that its commercialization process has accelerated, with overseas orders exceeding 60 units [1] - COSCO Shipping Energy Transportation Co., Ltd. (01138) increased over 3% following new sanctions announced by the U.S. OFAC against companies related to Iranian oil exports [1] - InnoCare Pharma-B (09606) gained over 3% as the company is expected to submit its first ADC for listing within the year [1] - Zijin Mining Group International (02259) rose over 4% after completing the acquisition of the Raygorodok gold mine project in Kazakhstan [1] - Hong Kong Travel International (00308) surged over 8% after announcing a proposal for the physical distribution of its tourism real estate business, which is expected to reduce the drag from non-core assets [1] - Kingsoft Corporation (03888) increased over 10% following the Chinese Ministry of Commerce's announcement of export controls on certain overseas rare earth-related items containing Chinese components [1] Group 2: Solar and Insurance Stocks - Solar stocks collectively declined, with Flat Glass Group Co., Ltd. (06865) down over 8%, Xinyi Solar Holdings Limited (00968) down over 7%, and Xinyi Glass Holdings Limited (00868) down over 6%, as the market focuses on capacity clearing and future installation demand [2] - Domestic insurance stocks fell across the board, with New China Life Insurance Co., Ltd. (01336) down over 5%, China Pacific Insurance (Group) Co., Ltd. (02328) down over 3%, and China Life Insurance Company Limited (02628) down nearly 4%, following Tianan Insurance's announcement of a 5.3 billion yuan debt default [2] Group 3: U.S. Stocks - Beike (BEKE.US) fell 3.87% as a report indicated that the sales of the top 100 real estate companies in September increased month-on-month, driven by seasonal factors and policy relaxations [3] - Stellantis (STLA.US) dropped 7.37% after preliminary third-quarter sales data showed a 13% year-on-year increase in global deliveries to 1.3 million units [3] - Intel (INTC.US) decreased 3.78% after revealing details about its new Core Ultra series processors [3] - Venture Global (VG.US) plummeted 24.88% after losing a legal dispute related to LNG cargo sales with BP [4] - Nokia (NOK.US) rose 2.70% after announcing a technology asset licensing agreement with HPE to enhance its AI wireless access network capabilities [4]

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) shares rose over 3%, currently trading at HKD 13.46 with a transaction volume of HKD 31.44 million, following the announcement of a share buyback plan [1] Group 1: Share Buyback Announcement - The company announced a share buyback authorization, with a maximum repurchase amount of HKD 20 million, subject to shareholder approval at the annual general meeting on June 12, 2025 [1] - The board believes that the current trading price does not accurately reflect the company's intrinsic value and that the buyback will demonstrate confidence in the company's business outlook and prospects [1] - The board is confident that the company's current financial resources are sufficient to support the proposed buyback while maintaining a robust financial position [1]

Group 1 - The stock of CanSino Biologics Inc. (09966.HK) increased by over 3%, specifically by 3.06%, reaching a price of 13.46 HKD [1] - The trading volume for CanSino Biologics Inc. was reported at 31.4396 million HKD [1]

Core Viewpoint - Corning Pharmaceutical-B (09966) has seen a stock price increase of over 3%, currently trading at 13.46 HKD with a transaction volume of 31.44 million HKD, following the announcement of a share buyback program [1] Group 1: Share Buyback Announcement - The board of directors has resolved to repurchase ordinary shares from the open market, with a maximum amount of 20 million HKD, subject to shareholder approval at the annual general meeting on June 12, 2025 [1] - The board believes that the current trading price does not accurately reflect the company's intrinsic value and that the buyback will demonstrate confidence in the company's business outlook and ultimately benefit shareholders [1] - The board is confident that the company's current financial resources are sufficient to support the proposed share buyback while maintaining a robust financial position [1]

格隆汇10月13日丨康宁杰瑞制药-B(09966.HK)宣布，根据董事获授出的一般授权(由股东于2025年6月12 日举行的股东周年大会上批准)，董事会于2025年10月12日决议不时自公开市场购回公司普通股，购回 股份的金额最高为2000万港元。 董事会认为股份的当前成交价并未准确反映公司内在价值，亦认为本次股份购回将体现公司对自身业务 展望及前景的信心，并最终令公司受益及为其股东创造价值。董事会相信，公司当前的财务资源足以支 持建议股份购回并维持稳健的财务状况。 ...

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a share buyback program, indicating that the current market price does not reflect the company's intrinsic value and expressing confidence in its business outlook and future prospects [1] Summary by Relevant Sections - **Share Buyback Authorization** - The board of directors resolved to repurchase ordinary shares from the open market, with a maximum amount of HKD 20 million [1] - This buyback is subject to approval at the shareholders' annual general meeting scheduled for June 12, 2025 [1] - **Rationale for Buyback** - The board believes that the current trading price of the shares does not accurately reflect the company's intrinsic value [1] - The buyback is seen as a demonstration of the company's confidence in its business outlook and future prospects [1] - The company aims to benefit from this buyback and create value for its shareholders [1] - **Financial Position** - The board is confident that the company's current financial resources are sufficient to support the proposed share buyback while maintaining a robust financial position [1]

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a share buyback program with a maximum amount of HKD 20 million, reflecting the board's confidence in the company's business outlook and intrinsic value [1] Summary by Relevant Sections Share Buyback Authorization - The board resolved to repurchase shares from the open market, subject to approval at the shareholders' annual meeting on June 12, 2025 [1] - The maximum amount for the share buyback is set at HKD 20 million [1] Rationale for Buyback - The board believes that the current trading price does not accurately reflect the company's intrinsic value [1] - The share buyback is seen as a demonstration of the company's confidence in its business prospects and aims to create value for shareholders [1] Financial Position - The board is confident that the company's current financial resources are sufficient to support the proposed share buyback while maintaining a robust financial position [1]